Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,829 | 111 | 98.3% |
| Education | $116.70 | 5 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,325 | 44 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $792.37 | 8 | $0 (2020) |
| Allergan, Inc. | $626.41 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $594.52 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $373.09 | 5 | $0 (2019) |
| ABBVIE INC. | $364.11 | 3 | $0 (2023) |
| United Therapeutics Corporation | $363.87 | 4 | $0 (2023) |
| Amarin Pharma Inc. | $302.54 | 5 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $298.58 | 3 | $0 (2019) |
| Novo Nordisk Inc | $276.90 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $630.89 | 6 | E.R. Squibb & Sons, L.L.C. ($241.16) |
| 2022 | $109.91 | 2 | United Therapeutics Corporation ($98.04) |
| 2021 | $572.10 | 5 | United Therapeutics Corporation ($125.00) |
| 2020 | $410.85 | 4 | Allergan, Inc. ($125.26) |
| 2019 | $1,429 | 29 | PFIZER INC. ($280.91) |
| 2018 | $2,151 | 26 | PFIZER INC. ($626.66) |
| 2017 | $1,642 | 44 | PFIZER INC. ($405.06) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2023 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $57.45 | General |
| 05/24/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $122.17 | General |
| 05/15/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $83.38 | General |
| Category: PAH | ||||||
| 04/13/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $123.90 | General |
| Category: INSOMNIA | ||||||
| 03/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $118.99 | General |
| Category: Cardiovascular | ||||||
| 03/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2022 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $98.04 | General |
| 02/14/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $114.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $119.91 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PAH | ||||||
| 09/14/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Cardio-renal | ||||||
| 06/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $91.09 | General |
| Category: DIABETES | ||||||
| 02/11/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $92.33 | General |
| Category: Cardiovascular | ||||||
| 01/23/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | Cash or cash equivalent | $125.26 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $97.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $96.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2019 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $84.51 | General |
| 11/14/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $96.53 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/29/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $98.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $78.77 | General |
| Category: Diabetes | ||||||
| 09/26/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Diabetes | ||||||
| 09/12/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $97.48 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: GASTROINTESTINAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 524 | 859 | $107,254 | $34,990 |
| 2021 | 10 | 771 | 1,085 | $127,112 | $70,428 |
| 2020 | 12 | 613 | 1,011 | $116,865 | $56,144 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 449 | $66,951 | $19,158 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 231 | $23,301 | $9,074 | 38.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 30 | 44 | $6,028 | $3,783 | 62.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $6,048 | $1,305 | 21.6% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 50 | 51 | $2,244 | $800.08 | 35.7% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 17 | 18 | $1,656 | $660.92 | 39.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 34 | 38 | $1,026 | $208.32 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 238 | 487 | $71,589 | $39,998 | 55.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 156 | 197 | $19,503 | $11,836 | 60.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 81 | 81 | $17,010 | $10,421 | 61.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 39 | 39 | $3,198 | $2,545 | 79.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 22 | 27 | $3,699 | $1,176 | 31.8% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 68 | 74 | $3,182 | $1,164 | 36.6% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 31 | 31 | $2,759 | $1,114 | 40.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 19 | 25 | $2,675 | $1,022 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $1,287 | $631.41 | 49.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 78 | 85 | $2,210 | $519.82 | 23.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 241 | 457 | $67,179 | $33,991 | 50.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 166 | 228 | $22,572 | $8,823 | 39.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 57 | 100 | $13,700 | $8,171 | 59.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 18 | 18 | $3,780 | $1,982 | 52.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 18 | 18 | $1,476 | $1,085 | 73.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 18 | 22 | $2,354 | $867.34 | 36.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 39 | $1,287 | $339.56 | 26.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 21 | 21 | $693.00 | $336.83 | 48.6% |
About Dr. Erwin Maseelall, MD
Dr. Erwin Maseelall, MD is a Internal Medicine healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982604013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erwin Maseelall, MD has received a total of $6,946 in payments from pharmaceutical and medical device companies, with $630.89 received in 2023. These payments were reported across 116 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($6,829).
As a Medicare-enrolled provider, Maseelall has provided services to 1,908 Medicare beneficiaries, totaling 2,955 services with total Medicare billing of $161,562. Data is available for 3 years (2020–2022), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Akron, OH
- Active Since 07/29/2005
- Last Updated 02/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982604013
Products in Payments
- VRAYLAR (Drug) $508.40
- EUCRISA (Drug) $505.59
- ELIQUIS (Drug) $424.94
- XARELTO (Drug) $328.64
- FARXIGA (Drug) $318.60
- Vascepa (Drug) $302.54
- Ozempic (Drug) $276.90
- INVOKANA (Drug) $265.88
- MYRBETRIQ (Drug) $250.00
- BEVESPI AEROSPHERE (Drug) $241.63
- BYDUREON (Drug) $232.14
- TRELEGY ELLIPTA (Drug) $217.39
- LYRICA (Drug) $201.54
- JARDIANCE (Drug) $183.25
- ENTRESTO (Drug) $145.13
- Actemra (Biological) $140.36
- NAMZARIC (Drug) $132.19
- UBRELVY (Drug) $125.26
- ORENITRAM (Drug) $125.00
- Synthroid (Drug) $124.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Akron
Hassan Malik, Md, MD
Internal Medicine — Payments: $1.6M
Dr. Amy Hite, M.d, M.D
Internal Medicine — Payments: $274,260
Dr. Mark Arredondo, Md, MD
Internal Medicine — Payments: $214,747
Dr. Kenneth Varian, Md, Phd, MD, PHD
Internal Medicine — Payments: $143,561
Dr. Ganesh Veerappan, Md, MD
Internal Medicine — Payments: $114,341
Laurie Matt-Amaral, M.d, M.D
Internal Medicine — Payments: $25,139